Supply Chain Intelligence

LIGAND PHARMACEUTICALS INC Supply Chain

LGNZZ supply chain intelligence for LIGAND PHARMACEUTICALS INC: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

LGNZZ ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
2Customers
2Debt Items
19Related Chains

LIGAND PHARMACEUTICALS INC Suppliers

TickerNameConfidenceEvidence
DNTH Dianthus Therapeutics, Inc. 72% Reciprocal relationship from DNTH graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from DNTH graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from DNTH…
VKTX Viking Therapeutics, Inc. 72% Reciprocal relationship from VKTX graph: from non-elective hip fracture surgery. However, VK5211, if approved, will face competition from experimental therapies that are in various stages of clinical…

LIGAND PHARMACEUTICALS INC Customers

TickerNameConfidenceEvidence
DNTH Dianthus Therapeutics, Inc. 72% Reciprocal relationship from DNTH graph: tents Cash Flows from Financing Activities For the year ended December 31, 2024, net cash provided by financing activities consisted of $215.3 million of net …
VKTX Viking Therapeutics, Inc. 72% Reciprocal relationship from VKTX graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from VKTX graph: from non-elective hip fracture surgery. However, VK5211, if approved, will …

LIGAND PHARMACEUTICALS INC Debt Obligations

InstrumentDescriptionConfidenceEvidence
LGNZZ-DEBT-10695 Warrants outstanding: 3264643 90% xbrl warrant detail from xbrl 2023-12-31.
LGNZZ-DEBT-10696 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

LIGAND PHARMACEUTICALS INC Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for LIGAND PHARMACEUTICALS INC.

LIGAND PHARMACEUTICALS INC Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for LIGAND PHARMACEUTICALS INC.

LIGAND PHARMACEUTICALS INC Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
VKTX Viking Therapeutics, Inc. 100.00 1 ['customer', 'supplier']
DNTH Dianthus Therapeutics, Inc. 100.00 1 ['customer', 'supplier']
BHC Bausch Health Companies Inc. 50.00 2
ORANY ORANGE 50.00 2
GYRE Gyre Therapeutics, Inc. 50.00 2
ALNY Alnylam Pharmaceuticals, Inc. 50.00 2
ARWR Arrowhead Pharmaceuticals, Inc. 50.00 2
GPCR Structure Therapeutics Inc. 50.00 2
IBIO iBio, Inc. 50.00 2
HEPA Hepion Pharmaceuticals, Inc. 50.00 2
MDGL Madrigal Pharmaceuticals, Inc. 50.00 2
SEPN Septerna, Inc. 50.00 2
SNYNF Sanofi 50.00 2
TERN Terns Pharmaceuticals, Inc. 50.00 2
MTVA MetaVia Inc. 50.00 2
GLMD Galmed Pharmaceuticals Ltd. 50.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 50.00 2
ZBIO Zenas BioPharma, Inc. 50.00 2
LGND Ligand Pharmaceuticals Incorporated 50.00 2
View LGNZZ supply chain intel →

Explore the full interactive supply chain map for LIGAND PHARMACEUTICALS INC.

Open LGNZZ supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map